Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Paricalcitol
Medication labelParicalcitol capsules are indicated for the prevention and treatment of secondary hyperparathyroidism associated with Chronic Kidney Disease…
Why this: Advisory · dailymed-prescription
Paricalcitol capsules are indicated for the prevention and treatment of secondary hyperparathyroidism associated with Chronic Kidney Disease (CKD) Stages 3 and 4. Paricalcitol capsules are indicated for the prevention and treatment of secondary hyperparathyroidism associated with CKD Stage 5 in patients on hemodialysis (HD) or peritoneal dialysis (PD).
- generic_name
- paricalcitol
- product_names
- PARICALCITOL
- ndc
- 69387-103, 69387-104, 69387-105, 69387-103-30, 69387-104-30, 69387-105-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en